Table of contents

IBME contributes to new GSPI Policy Brief "Governance in the age of complexity: building resilience to COVID-19 and future pandemics“

Nikola Biller-Andorno is among an international team of scientists that has drawn up a report on the resilience capacity needed by our societies to prevent, react to and recover from the COVID-19 crisis.

See press release (PDF, 212 KB) for more information.

date 25.3.2021

Event: Invitation to Forum for Global Health Ethics: Equitable Access to Covid-19 Vaccines

March 29, 2021 | 2:30pm to 4pm CET / 8:30am to 10am ET | Online 

Dear colleagues,

We would like to invite you to the Forum for Global Health Ethics: Equitable Access to Covid-19 Vaccines, an online event organized jointly by the Institute of Biomedical Ethics and History of Medicine (IBME) at the University of Zurich, the Swiss Medical Weekly, and FLACSO Argentina. This forum is kindly supported by the Berlin-Brandenburg Academy of Sciences and Humanities, the World Health Summit and the European Association of Centres of Medical Ethics.

At this time of the pandemic, we face the impossibility of having enough Covid-19 vaccines for everyone in the near future. While some high-income countries have launched massive Covid-19 vaccination campaigns, in many low and middle-income countries vaccination has barely started, leaving their most vulnerable groups and health care workers unprotected. Some argue that governments have the duty to give priority to its own population before helping citizens abroad; others claim that vaccines should be allocated equitably at the global level; and others hold views in between.

In this forum, we open the floor to a discussion about the priority of values and ethical principles that should guide vaccine allocation. Experts who hold different views on equitable access to Covid-19 vaccines will present their arguments, discuss with other speakers, and answer questions from the audience.

Our speakers are:

The chair of the forum is Nikola Biller-Andorno, and the moderators are Tania Manríquez Roa and Felicitas Holzer (all three are members of the IBME).  
Please help us disseminate this event.


Prof. Dr. med. Dr. phil. Nikola Biller-Andorno
Prof. Dr. med. Adriano Aguzzi

Download FLYER (PNG, 513 KB)


date: 3.3.2021

Medien: spricht mit Nikola Biller-Andorno über Impfprivilegien spricht im Artikel «Coronavirus: Wie weit sollen die Impfprivilegien gehen?» mit Nikola Biller-Andorno über die Problematik der Impfprivilegien im Zusammenhang mit der COVID-19 Pandemie.

Link zum Artikel

date: 1.3.2021

Medien: Nikola Biller-Andorno im Interview mit der NZZ zur Verteilung unterschiedlich wirksamer Impfstoffe

Im Interview mit der NZZ äussert sich Nikola Biller-Andorno zu ethischen Aspekten der Verteilung von COVID-19 Impfstoffen, wenn diese unterschiedliche Wirksamkeiten haben.

Link zum Text

date: 12.2.2021

Medien: Tanja Krones äussert sich in der NZZ zur Impfstoffverteilung

Im Artikel der NZZ «Corona-Impfung für Todkranke? Die Knappheit stellt Mediziner vor ein Dilemma» kommt Tanja Krones zu ethischen Aspekten der Verteilung der knappen COVID-19 Impfstoffen zu Wort.

Link zum Text

date: 11.2.2021

New Grant: grant approved to foster collaboration between IBME and University of Geneva on pandemic resilience.

The IBME has obtained a grant from the call «Shaping resilient and responsive societies and ecosystems in view of global crises», which is part of the UNIGE - UZH Joint Funding for Collaboration in Research and Teaching. The grant will allow Nikola Biller-Andorno, IBME, and Stéphanie Dagron, UniGe to work together with a joint team that explores the role of global health law, ethics and human rights in fostering resilient societies. 

date: 11.2.2021

Medien: Tanja Krones kommt im Tagesanzeiger zur Moralisierung im Zusammenhang mit COVID-19 Massnahmen zu Wort

Im Tagesanzeiger Artikel Müssen bald alle geimpft werden – selbst die Kinder? äussert sich Tanja Krones zur Moralisierung der COVID-19 Pandemie «Sich selber oder dann auch andere anzustecken, das ist extrem mit Scham und Schuldgefühlen belastet.»

Link zum Text

date: 8.2.2021

Medien: Nikola Biller-Andorno auf zu Bürgerbeteilung und der PubliCo-Plattform während der Corona-Krise

Im Beitrag «Die politische Kultur der Schweiz ist eine Stärke, die es zu nutzen gilt» äussert sich Nikola Biller-Andorno auf zur Direkten Demokratie und der traditionellen Partizipation in der Schweiz als unterschätzter Ressource im Umgang mit der Corona-Krise. Ausserdem verweist sie auf die, im Rahmen eines vom Schweizerischen Nationalfonds, der Weltgesundheitsorganisation und vom Collegium Helveticum geförderten Projektes, ins Leben gerufene Plattform PubliCo hin.

Link zum Text

date: 29.1.2021

Medien: Tanja Krones kommt im Artikel der Zeit zu den sozioökonomischen Hintergründen der COVID-19 Pandemie zu Wort

Im Artikel «Corona und Armut: Das Leiden der anderen» äussert sich Tanja Krones zum Umstand dass auch in der Schweiz ärmere Bevölkerungsschichten stärker von der COVID-19 Pandemie betroffen sind als andere, dass dies in der Öffentlichkeit und Politik aber kaum bis gar nicht diskutiert wird.

Link zum Text

date: 17.1.2021

Medien: Nikola Biller-Andorno im Interview mit SRF zum Thema: "Lassen wir ältere Menschen aus Bequemlichkeit sterben?"

Nikola Biller-Andorno spricht mit Isabelle Maissen in SRF News über den Umgang der Schweiz mit den älteren Teilen der Gesellschaft im Angesicht der vergleichsweise vielen Corona-Toten.

zum Audiobeitrag

Publication: Tania Manríquez Roa and Nikola Biller-Andorno published "Going first: the ethics of vaccine self-experimentation in coronavirus times"

Tania Manríquez Roa and Nikola Biller-Andorno published "Going first: the ethics of vaccine self-experimentation in coronavirus times" in Medical News Weekly.

In the context of the COVID-19 pandemic, a number of scientists have been conducting experiments on themselves with the goal of finding a vaccine against the virus. Based on the premise that exceptional times demand exceptional actions, the urgency to find and develop a vaccine for COVID-19 has fuelled a renewed debate on the ethics of self-experimentation.

In the times of the coronavirus pandemic, the timely development of a vaccine has an immense potential to improve global health. In this context, self-experimentation may be a valuable means to achieve faster pre-research results, which, if promising, could undergo standard vaccine trials. 

However, self-experiments may backfire on public trust if done in risky ways. If self-experimentation is conducted without ethical approval, if researchers are put under undue pressure to try vaccines in themselves, or if self-experimenters start distributing vaccines that have not undergone standard trials, the public may lose confidence in science. The potential role of self-experimentation in the search for a vaccine is in urgent need of further clarification.

Link to article

date: 4.12.2020

Forum for Global Health Ethics: Self-Experimentation in Times of Covid-19

December 16, 2020 | 16:00 to 17:30 CET / 10:00 to 11:30 ET | Online (click here to join the event, password: 756424)

Dear colleagues,

We would like to invite you to the Forum for Global Health Ethics: Self-Experimentation in Times of Covid-19, an online event organized jointly by the Institute of Biomedical Ethics and History of Medicine at the University of Zurich and the Swiss Medical Weekly.

In the context of the Covid-19 pandemic, several scientists have been conducting experiments on themselves with the goal of finding a vaccine against the virus, fuelling a renewed debate on ethics and self-experimentation. 

In this forum, experts who hold different views on self-experimentation will present and discuss their arguments, and answer questions from the audience. Speakers are:

Prof Rebecca Dresser (Daniel Noyes Kirby Professor, Washington University in St. Louis)
Prof Preston Estep (Founder, Rapid Deployment Vaccine Collaborative — RaDVac)
Prof Samia Hurst-Majno (Director of the Institute for Ethics, History and Humanities, University of Geneva)
Dr Peter Kleist (Director, Zurich Cantonal Ethics Committee)

The main interventions in the forum will be transcribed and published as proceedings by the Swiss Medical Weekly.  In the meantime we invite you to read our introductory article on the topic just published on the occasion of this forum.

Please feel free to promote this event within your network.


Prof. Dr. med. Dr. phil. Nikola Biller-Andorno
Institute of Biomedical Ethics and History of Medicine, University of Zurich
Deputy Editor
Swiss Medical Weekly

Prof. Dr. med. Adriano Aguzzi
Editor in chief
Swiss Medical Weekly
Institute of Neuropathology
Universitätsspital Zürich

Publication: Susanne Jöbges, Rasita Vinay, Valeria Luyckx and Nikola Biller published «Recommendations on COVID‐19 triage: international comparison and ethical analysis»

Susanne JöbgesRasita VinayValerie A. Luyckx and Nikola Biller-Andorno published the article, «Recommendations on COVID-19 triage: international comparison and ethical analysis» in Bioethics Volume 34, Issue 9

On March 11, 2020 the World Health Organization classified COVID‐19, caused by Sars‐CoV‐2, as a pandemic. Although not much was known about the new virus, the first outbreaks in China and Italy showed that potentially a large number of people worldwide could fall critically ill in a short period of time. A shortage of ventilators and intensive care resources was expected in many countries, leading to concerns about restrictions of medical care and preventable deaths. In order to be prepared for this challenging situation, national triage guidance has been developed or adapted from former influenza pandemic guidelines in an increasing number of countries over the past few months. In this article, we provide a comparative analysis of triage recommendations from selected national and international professional societies, including Australia/New Zealand, Belgium, Canada, Germany, Great Britain, Italy, Pakistan, South Africa, Switzerland, the United States, and the International Society of Critical Care Medicine. We describe areas of consensus, including the importance of prognosis, patient will, transparency of the decision‐making process, and psychosocial support for staff, as well as the role of justice and benefit maximization as core principles. We then probe areas of disagreement, such as the role of survival versus outcome, long‐term versus short‐term prognosis, the use of age and comorbidities as triage criteria, priority groups and potential tiebreakers such as ‘lottery’ or ‘first come, first served’. Having explored a number of tensions in current guidance, we conclude with a suggestion for framework conditions that are clear, consistent and implementable. This analysis is intended to advance the ongoing debate regarding the fair allocation of limited resources and may be relevant for future policy‐making.

Link zum Artikel

date: 2.12.2020

Medien: Nikola Biller-Andorno kommt im Artikel von 20min zu Wort

Nikola Biller-Andorno äussert sich im Artikel «Corona-Skeptikern ein Intensivbett zu verweigern, ist ein No-go» zur Frage der Verteilung begrenzter Ressourcen im Gesundheitswesen.

date: 18.11.2020

Medien: Tanja Krones kommt im Artikel von 20min zu Wort

Tanja Krones kommt im Artikel «Wer erhält im Ernstfall das letzte Bett auf der Intensivstation?» zu den aktualisierten SAMW Richtlinien für eine allfällige Triage zu Wort.

date: 14.11.2020

Grant: IBME and FLACSO Argentina collaborate on project funded by the World Health Organization

Prof Nikola Biller-Andorno (IBME), Dr Florencia Luna, head of the bioethics program at FLACSO Argentina, and Dr Felicitas Holzer, a Stehr-Boldt fellow at IBME, obtained a research grant in response to a WHO call on Ethics of Public Health Emergency Preparedness and Response. The project seeks to address the challenges to global equitable COVID-19 vaccine access through the COVAX facility, a global risk-sharing mechanism for pooled procurement and fair distribution of future COVID-19 vaccines. The researchers will specifically explore how both high and middle-income countries realize cooperation with COVAX, having to juggle commitments to their national populations as well as to global fair vaccine allocation. The project includes case analyses of Argentina, Peru, Kazakhstan, Switzerland, and Germany.

date: 12.11.2020

Media: Supriya Subramani interviews Dr. Usha Sriram

In this two series podcast Supriya Subramani interviewed Dr. Usha Sriram who is an endocrinology and diabetes specialist.

In the first podcast, Usha highlights many aspects of being ethical, and practicing ethics in everyday clinical practice. She touches upon the cultural challenges, particularly in the Indian context, and reflects on the experiences she had with her patients.

In the second podcast, she shares her personal experience of being diagnosed with COVID-19 and ethical issues she encountered.

date: 4.11.2020

Research Project: Project Grant from ETH Zurich and the State Secretariat for Education, Research and Innovation

Nikola Biller-Andorno, together with Calvin Ho (University of Hong Kong) and Renate Schubert (Singapore ETH Center) receives a Special COVID-19 Project Grant from ETH Zurich and the State Secretariat for Education, Research and Innovation. The grant will allow the team to explore if the PubliCo platform for the study of COVID-19-related public perception is transferable to selected Asian contexts. 

date: 29.10.2020

Media: Supriya Subramani interviews Valerie Luyckx (Podcast)

The growth of Non-Communicable Diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are concerning, and are among the leading causes of death and disability in the world. Prevention and control of NCDs are important during this pandemic because NCDs are major risk factors for patients with COVID-19. Furthermore, some of the restrictive measures such as lockdowns, social distancing, and travel restrictions to reduce the spread of infection in many countries impact specifically on people living with NCDs. In today’s podcast, we will be talking to Valerie Luyckx, who is a trained medical professional and strong global advocate for patients with kidney disease.

Speaker: Valerie Luyckx, Faculty, Institute of Biomedical Ethics and History of Medicine,  University of Zurich, Switzerland; and Brigham and Women’s Hospital, Harvard Catalyst, Boston, MA, USA.

Anchor and producer: Supriya Subramani, Postdoctoral Fellow (ESKAS Scholar) at the Institute of Biomedical Ethics and History of Medicine, University of Zurich.

date: 29.8.2020

Media: Settimio Monteverde spricht über den Lockdown in Pflegeeinrichtungen

Bewohnerinnen und Bewohner von Langzeiteinrichtungen wurden in der Corona-Pandemie schon früh als besonders vulnerable Gruppe identifiziert. Als Reaktion darauf wurden in der Schweiz und in den meisten anderen Ländern Freiheitsrechte eingeschränkt, wie z.B. das Recht auf Bewegung und der Besuch durch Angehörige. In einem Interview mit der Zeitschrift Zeitlupe von Pro Senectute nimmt Settimio Monteverde, Mitarbeiter am Institut für Biomedizinische Ethik und Medizingeschichte sowie Klinischer am Universitätsspital Zürich, dazu persönlich Stellung und zeigt ethische Perspektiven im Spannungsfeld zwischen Lebensschutz und Lebensqualität auf (Upload mit freundlicher Genehmigung  der Zeitschrift Zeitlupe / Pro Senectute). 

PDF des Interviews (PDF, 801 KB)

date: 26.8.2020

Publication: Tanja Krones, Gabriele Meyer and Settimio Monteverde published: «Medicine is a social science: COVID-19 and the tragedy of residential care facilities in high-income countries»

In the context of the pandemic spread of COVID-19, the majority of high-income countries have witnessed an extraordinary high death toll of people living in residential care facilities.

Social epidemiology makes an important contribution to better understand this phenomenon, attributable to the biological impact of the pathogen on vulnerable high-risk populations and to the place of care as a decisive social determinant of health.

The tragedy of COVID-19 related deaths in nursing homes is primarily due to its iatrogenic spread and aggravated by socioeconomic circumstances.

Current isolation and confinement policies, including the prolonged separation of residents from their loved ones have failed to show their effectiveness in preventing these developments and are therefore disproportionate. They have to be replaced by policies that respect both the needs of safety of all residents and basic human rights.

In addition to the questionable effectiveness, these policies bear considerable opportunity costs, as they negatively affect quality of life and health outcomes of isolated residents.

Seen through the lens of medicine as a social science and of social epidemiology in particular, the COVID-19 crisis provides opportunities to better understand and fundamentally improve framework conditions within residential care facilities as well as other ‘large households’ all over the globe and to build safer institutions for all people in need of continuous care.


date: 14.8.2020

Publication: COVID-19 and the ethics of quarantine: a lesson from the Eyam plague

Giovanni Spitale published a new paper in Medicine, Health Care and Philosophy on the ethical aspects of quarantine ethics.


The recent outbreak of the SARS-CoV-2 coronavirus is posing many different challenges to local communities, directly affected by the pandemic, and to the global community, trying to find how to respond to this threat in a larger scale. The history of the Eyam Plague, read in light of Ross Upshur’s Four Principles for the Justification of Public Health Intervention, and of the Siracusa Principles on the Limitation and Derogation Provisions in the International Covenant on Civil and Political Rights, could provide useful guidance in navigating the complex ethical issues that arise when quarantine measures need to be put in place.


History of medicine, History of epidemiology, Eyam, Plague, SARS-CoV-2, COVID-19, Public health ethics

Full text

date: 6.8.2020

Media: SRF 4 News aktuell: Interview mit Nikola Biller-Andorno

Nikola Biller-Andorno argumentiert im Interview mit SRF 4 News aktuell vom 3.8.2020 dafür, dass der Basler Pharmakonzern Roche sich in der aktuellen Pandemie mit anderen Pharmafirmen austauschen und Hand dafür bieten sollte, das Problem der fehlenden Testkapazitäten für Coronatests zu lösen.

date: 3.8.2020

Publication: Science Alone Can’t Solve Covid-19. The Humanities Must Help.

Anna Elsner and Vanessa Rampton have published an opinion piece in Undark Magazine, published through the Knight Science Journalism Program at the Massachusetts Institute of Technology, about the role of humanities research in shaping responses to the COVID-19 pandemic:

date: 16.7.2020

Publication: The Ethical Use of Telepsychiatry in the Covid-19 Pandemic

Julia Stoll, John Z. Sadler and Manuel Trachsel published a new article on telepsychiatry ethics during the COVID-19 pandemic.

In a statement to the press, Dr. Hans Henri P. Kluge, World Health Organization (WHO) Regional Director for Europe, stressed that it is important not to lose sight of the mental health implications of Covid-19 for everyone, noting that “[i]t is absolutely natural for each of us to feel stress, anxiety, fear, and loneliness during this time” (1). If mentally healthy individuals react with fear and stress to the Covid-19 pandemic, it is not difficult to imagine that such reactions make those who have mental disorders especially vulnerable to harm.

Challenges for Patients With Mental Disorders in Times of Covid-19
Yao, Chen, and Xu (2) listed four reasons to explain why patients with mental disorders may be at particular risk in the Covid-19 pandemic. First, patients with mental disorders may be at increased risk of infection because they are less aware of the dangers or because they adhere less to official measures. Second, poor symptom recognition combined with stigmatization means that Covid-19 infection may not be detected as quickly, and treatment following infection may be compromised by various psychiatric comorbidities. Third, patients with mental disorders may be more vulnerable to the public panic and anxiety triggered by the pandemic, which may aggravate the symptoms of the underlying mental disease. Finally, face-to-face outpatient treatment may be impeded as a result of various government measures, including quarantine. Importantly, the undersupply of services for patients with mental disorders not only increases existing healthcare inequities but potentially facilitates the spread of Covid-19 through increased infection and difficulties with adherence with public health restrictions among these patients (2). How can continuous care for patients with mental disorders be guaranteed within the confines of social distancing?

Telepsychiatry as a Possible Solution
Telepsychiatry has been discussed as a possible solution for the care of patients with mental disorders (3, 4) and is increasingly used worldwide during the Covid-19 pandemic (5). Telepsychiatry is already well established in some countries like Australia and Canada and the effectiveness of telepsychiatry, as well as the satisfaction of its users, has been shown in various studies (6–8).

Especially in a crisis like the Covid-19 pandemic, the treatment of patients through telepsychiatry shows some specific advantages: Because telepsychiatry services maintain social distance, they eliminate the risk of infection for both patients and therapists; the patient can remain at home, and the therapist can work from their home, office, or practice. In this way, psychotherapy can be maintained or initiated even under quarantine. Patients who would otherwise attend for outpatient psychotherapy can continue their treatment remotely with the same therapist, so ensuring continuity of care and potentially improving compliance and adherence. Telepsychiatry makes even brief crisis intervention possible when physical distance prevents inpatient treatment, so potentially reducing the number of hospitalizations during the Covid-19 pandemic.

Full text

date: 15.7.2020

Media: Settimio Monteverde launches call for urgent reflection about ethical isolation policies in nursing homes in the case of a „second wave“

Within the actual pandemic, lockdown policies and bans of visits in nursing homes have followed the objective of protecting the lives of the most vulnerable. But they have also provoked much suffering for residents, relatives, and healthcare professionals. In a declaration published in the Swiss Medical Review, over 100 medical ethicists have highlighted that the protection of life cannot be pursued without protecting the quality of life, the rights and interests of the person, and, if lacking decision-making capacity, the right of being legally represented in medical decisions.  

Swiss Medical Review

Interview Radio DRS

date: 9.7.2020

Media: NZZ-Standpunkte: Corona-Massnahmen in der Kritik: «Mit dem Besuchsverbot sind wir definitiv zu weit gegangen»

In Alters- und Pflegeheimen sterben Menschen seit Corona oft allein. Die Medizinethikerin Tanja Krones spricht in «NZZ Standpunkte» über Verfehlungen der Wissenschaft, eine zweite Welle und darüber, wie viel ein Menschenleben wert ist.


date: 8.6.2020

As the Corona Virus (SARS-CoV-2) continues to spread globally, causing severe human disease and death (COVID-19), citizens around the world have been exposed to crisis communication from a diverse spectrum of media outlets, including websites of public health authorities and universities, newspapers, television broadcasts, and social media platforms.

These policy briefings, expert opinions, popular sentiments as well as dashboards, interactive maps and visuals, have not only become sources of information but also an incubator for emotional responses, moral judgements, and behavioral changes in daily routines, during a public health emergency. 

An interdisciplinary team of researchers from the DSI, the Collegium Helveticum, the IBME, and the SwissTPH has come together to develop an experimental, interactive online platform that helps tackle the “infodemic” manifested in the COVID-19 context, with a focus on a nuanced and in-depth understanding of public perception. 

Building on real-time data, continuous data collection through a participatory citizen science approach and advanced, AI-based analytics, the highly adaptable platform aims to foster effective and tailored risk and crisis communication in Switzerland and other countries, to help mitigate negative social effects of COVID-related policies and to provide insights for an emerging ethical framework for public health crisis communication and policy-making.


date: 19.5.2020

Publication: Ethics guidelines on COVID-19 triage - an emerging international consensus

Susanne Joebges and Nikola Biller-Andorno published in "Critical Care" a paper reviewing international guidelines on the triage of COVID-19 patients.


COVID-19—classified as a pandemic by the WHO on March 11, 2020—is expected to put tremendous strain on many healthcare systems. Early epidemiological analyses show that compared to the seasonal flu, COVID-19 patients may require ventilation much more frequently. This can lead to a shortage of ventilators and intensive care resources, resulting in limited medical care and death. Whereas some countries have been exposed very early, others had the opportunity to prepare for the ethical challenges that emerge when intensive care resources become scarce.

In everyday medical practice, ventilation may be withheld or withdrawn if it is not or no longer indicated or against a patient’s will. In crisis situations, such as pandemics, this practice is superimposed by an additional triaging process. Medical factors of triage recommendations typically contain exclusion criteria, a mortality assessment (e.g., Sequential Organ Failure Assessment (SOFA) score), and a re-evaluation requirement. Beyond the medical aspects, however, triaging unavoidably involves moral choices. The main ethical considerations for making such choices concern equity and maximizing benefits. Other criteria such as considering life stages, rewarding prosocial behavior, or giving priority to the worst off have been subject to long-standing controversy.

Full text

date: 13.5.2020

Media: Salience of effective public communication and transparency during Covid-19

Supriya Subramani, postdoctoral fellow at the IBME, recently published an article on the blog of HEaL Institute & IJME discussing public communication strategies, transparency and inclusivity during the Covid-19 epidemic.


On April 14, 2020, the three-week lockdown was extended till May 03. Following the announcement, Bandra Railway station and few other places saw thousands of migrant workers coming out in protest and demanding to be allowed to return to their homes. We all witnessed the hardships of migrant workers following the initial announcement of the lockdown on March 25, 2020. One wonders if the governments—both at the center and state—considered inclusive approaches in planning out their strategies, while also considering how they affect citizens, particularly the marginalized and vulnerable groups. In this piece, I emphasize that the two intertwined ethical issues, transparent effective communication and inclusive decisions, based on justice are non-negotiable ethical obligations by the state during pandemics, such as Covid-19.

Full text:

date: 17.4.2020

Media: Schreiben und Lesen in Zeiten von Corona

Wie beeinflusst der medizinische Alltag das literarische Schaffen? Und wie wirken sich die Arbeiten von Autorinnen und Autoren auf unsere Wahrnehmung von Medizin aus? Literaturwissenschaftlerin Anna Elsner erforscht am Beispiel der französischen Literatur diese Phänomene, die gerade in Zeiten von Corona besonders interessieren.

Zum Interview

date: 16.4.2020

Research Project: Individual experiences with pandemic SARS-CoV2 (COVID-19)

The DIPEx Team of IBME decided to start a module on COVID-19. This research project aims to clarify what we can comprehend from the experiences of COVID-19 survivors from the countries that participate to this study. 
This research project aims to provide information and support to patients, families, carers, friends and healthcare professionals about the experience of and recovery from COVID-19, and consequently to understand how response strategies (intended both on a clinical and on a social level) to the current public health crisis and to future significant threats to public health can be reshaped and ameliorated, learning from recovered patients with lived experience of COVID-19. 

Project Page

date 15.4.2020

Media: Warum wir wirkliches ACP und kein «ACP light» brauchen

In der aktuellen Corona-Krise wendet sich Tanja Krones, leitende Ärztin Klinische Ethik am Universitätsspital Zürich, mit einem eindringlichen Votum an die Öffentlichkeit, angeregt durch einen Leitartikel im digitalen Magazin «Republik». «ACP light» - in der Hektik der Pandemie erstellte Patientenverfügungen - berge die Gefahr, nicht den Menschen ins Zentrum zu stellen, sondern das Bedürfnis des Systems nach klaren Anweisungen zu erfüllen.

Zum offenen Brief

date: 8.4.2020

Media: Leben und Sterben in Zeiten der Seuche. Artikel von Nina Streeck über ethische Fragen der Triage in der Republik

Die Ausbreitung des Coronavirus könnte dazu führen, dass die Betten auf den Intensivstationen und die Beatmungsgeräte knapp werden. In diesem Fall müssten die Behandlungsteams eine Triage durchführen und entscheiden, welche Patienten die Intensivtherapie erhalten. Mit den ethischen Aspekten solcher Entscheidungen hat sich Nina Streeck in einem Artikel für die "Republik" befasst.

Zum Artikel

date: 30.3.2020

Publication: Checkliste ÄNO (Ärztliche Notfallanordnung) für Ärztinnen und Ärzte

Tanja Krones und Isabelle Karzig waren an der Erstellung der Checkliste Ärztliche Notfallanordnung für Ärztinnen und Ärzte (ÄNO) als Autorinnen beteiligt. Diese ist Teil der Gesundheitliche Vorausplanung mit Schwerpunkt Advance Care Planning. Siehe dazu das Rahmenkonzept des Bundesamtes für Gesundheit Gesundheitliche Vorausplanung mit Schwerpunkt Advance Care Planning. Sie steht auf unter «ACP und Covid-19» mit anderen Dokumenten zum Thema zum Download bereit.

date: 26.3.2020

Publication: Wegleitung für die «Patientenverfügung ACP-Kurzform»

Tanja Krones und Isabelle Karzig waren an der Erstellung der Wegleitung für die «Patientenverfügung ACP-Kurzform» für Patientinnen und Patienten als Autorinnen beteiligt. Sie steht auf unter «ACP und Covid-19» mit anderen Dokumenten zum Thema zum Download bereit.

date: 26.3.2020

Media: Tanja Krones bei SRF Sternstunde Philosophie: Corona – Eine Mikrobe stellt unsere Stärke in Frage

Die Pandemie hat die Welt im Griff. Die moderne Gesellschaft, die alles im Griff zu haben meint, kollabiert vor einer Mikrobe. Dem Virus sind die Menschen egal, es hat es nicht auf sie abgesehen. Wie geht der Mensch mit dieser Kränkung um? Und wie bleibt man menschlich angesichts der Krise?

«An Viren zu sterben, ist voll Achtziger, der moderne Mitteleuropäer stirbt vorwiegend an seinen schlechten Gewohnheiten, die ihm irgendwann die Gefässe dichtmachen», schrieb Barbara Plagg, italienische Dozentin für Sozialmedizin, kürzlich in einem Blog. Die Coronakrise erschüttert die Gesellschaft in ihrem Fortschrittsglauben und ihrem Vertrauen in die Spitzenmedizin. Sie hat die Natur nicht mehr im Griff, sondern kann nur versuchen, auf Zeit zu spielen, sich einzuigeln, sich abzuschotten. Das Virus trifft die Menschheit damit auch im Urmenschlichen, nämlich im Bedürfnis nach Gemeinschaft. Wie wird die Gesellschaft die Krise bewältigen? Barbara Bleisch diskutiert mit dem Physiker und Philosophen Eduard Kaeser, mit der Medizinethikerin Tanja Krones und dem Journalisten und Philosophen Daniel Binswanger über den taumelnden Menschen in Zeiten der Unsicherheit.


date: 22.3.2020